AALL1331; Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467 NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
